RJA
ASML icon

Raymond James & Associates’s ASML ASML Stock Holding History

Raymond James & Associates’s Portfolio ASML Stock Details ASML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$173M Buy
207,552
+5,407
+3% +$4.83M 0.11% 167
2024
Q2 		$207M Sell
202,145
-3,735
-2% -$3.59M 0.14% 127
2024
Q1 		$200M Buy
205,880
+14,090
+7% +$12.5M 0.14% 131
2023
Q4 		$145M Buy
191,790
+11,076
+6% +$7.31M 0.11% 165
2023
Q3 		$106M Buy
180,714
+6,234
+4% +$4.14M 0.09% 196
2023
Q2 		$126M Buy
174,480
+13,863
+9% +$9.43M 0.1% 178
2023
Q1 		$109M Buy
160,617
+13,503
+9% +$8.67M 0.09% 192
2022
Q4 		$80.4M Buy
147,114
+4,509
+3% +$2.36M 0.07% 248
2022
Q3 		$59.2M Sell
142,605
-12,126
-8% -$6.08M 0.06% 277
2022
Q2 		$73.6M Buy
154,731
+6,221
+4% +$3.47M 0.07% 247
2022
Q1 		$99.2M Sell
148,510
-9,430
-6% -$6.32M 0.08% 209
2021
Q4 		$126M Buy
157,940
+2,511
+2% +$1.99M 0.1% 180
2021
Q3 		$116M Buy
155,429
+3,517
+2% +$2.76M 0.1% 176
2021
Q2 		$105M Buy
151,912
+10,936
+8% +$7.21M 0.1% 189
2021
Q1 		$87M Buy
140,976
+823
+0.6% +$456K 0.09% 198
2020
Q4 		$68.4M Buy
140,153
+23,332
+20% +$9.82M 0.08% 226
2020
Q3 		$43.1M Sell
116,821
-530
-0.5% -$198K 0.05% 281
2020
Q2 		$43.2M Sell
117,351
-837
-0.7% -$263K 0.06% 276
2020
Q1 		$30.9M Sell
118,188
-12,914
-10% -$3.67M 0.05% 316
2019
Q4 		$38.8M Sell
131,102
-12,954
-9% -$3.5M 0.05% 338
2019
Q3 		$35.8M Sell
144,056
-15,841
-10% -$3.57M 0.05% 341
2019
Q2 		$33.2M Buy
159,897
+8,039
+5% +$1.6M 0.05% 371
2019
Q1 		$28.6M Buy
151,858
+8,884
+6% +$1.57M 0.04% 394
2018
Q4 		$22.3M Sell
142,974
-1,799
-1% -$305K 0.04% 434
2018
Q3 		$27.2M Sell
144,773
-8,091
-5% -$1.62M 0.04% 417
2018
Q2 		$30.3M Sell
152,864
-6,518
-4% -$1.31M 0.05% 356
2018
Q1 		$31.6M Sell
159,382
-3,097
-2% -$610K 0.06% 314
2017
Q4 		$28.2M Buy
162,479
+7,079
+5% +$1.25M 0.05% 352
2017
Q3 		$26.6M Buy
155,400
+11,658
+8% +$1.79M 0.05% 347
2017
Q2 		$18.7M Buy
143,742
+5,525
+4% +$731K 0.04% 453
2017
Q1 		$18.4M Buy
138,217
+4,980
+4% +$612K 0.04% 425
2016
Q4 		$14.9M Buy
133,237
+5,721
+4% +$599K 0.04% 472
2016
Q3 		$14M Buy
127,516
+1,733
+1% +$183K 0.04% 464
2016
Q2 		$12.5M Buy
125,783
+12,057
+11% +$1.17M 0.04% 471
2016
Q1 		$11.4M Buy
113,726
+2,515
+2% +$227K 0.04% 476
2015
Q4 		$9.87M Sell
111,211
-105
-0.1% -$9.56K 0.04% 524
2015
Q3 		$9.79M Buy
111,316
+4,088
+4% +$387K 0.04% 484
2015
Q2 		$11.2M Buy
107,228
+35,373
+49% +$3.78M 0.04% 474
2015
Q1 		$7.26M Sell
71,855
-2,753
-4% -$289K 0.03% 577
2014
Q4 		$8.04M Buy
74,608
+2,562
+4% +$260K 0.04% 486
2014
Q3 		$7.12M Buy
72,046
+4,185
+6% +$394K 0.04% 470
2014
Q2 		$6.33M Buy
67,861
+23,320
+52% +$2.01M 0.04% 527
2014
Q1 		$4.16M Buy
44,541
+10,802
+32% +$962K 0.03% 654
2013
Q4 		$3.16M Buy
33,739
+2,417
+8% +$224K 0.02% 726
2013
Q3 		$3.09M Buy
31,322
+2,132
+7% +$192K 0.03% 671
2013
Q2 		$2.31M Buy
+29,190
New +$2.21M 0.02% 740

Other funds holding ASML

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James & Associates's ASML Position: Q3 2024 in Review

Raymond James & Associates increased its ASML (ASML) stake by 2.7% in Q3 2024, buying an estimated $4.83M and bringing the position to 207,552 shares worth $173M. The position accounts for 0.11% of the portfolio, ranked #167.

Raymond James & Associates first reported a position in ASML in Q2 2013 and has held it in 46 quarters since. The position peaked at $207M in Q2 2024. 1,531 funds tracked by Wall St. Rank hold ASML as of Q3 2024.

  • Raymond James & Associates held 207,552 shares of ASML worth $173M as of Q3 2024.
  • Raymond James & Associates bought 5,407 ASML shares in Q3 2024, an estimated $4.83M.
  • ASML made up 0.11% of Raymond James & Associates's portfolio in Q3 2024, its #167 holding.
  • Raymond James & Associates first reported a position in ASML in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's ASML position peaked at $207M in Q2 2024.
  • 1,531 funds tracked by Wall St. Rank held ASML as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.